Epithelium removal alters responsiveness of guinea pig trachea to substance P.
Removal of epithelium from mammalian tracheae has been shown to enhance responsiveness to a variety of contractile and relaxant agents. One of the most dramatic shifts reported has been for guinea pig tracheal tissue denuded of epithelium and treated with substance P. We investigated whether this shift in responsiveness was because of 1) removal of an epithelium-associated enzyme, neutral endopeptidase, which degrades substance P and 2) loss of an epithelium-derived noncyclooxygenase relaxant factor. Using a muscle bath preparation we performed concentration-response curves with substance P and acetylcholine on indomethacin-treated tissues with and without intact epithelium and with and without pretreatment with the neutral endopeptidase inhibitor, phosphoramidon. Epithelium removal potentiated the mean agonist concentration calculated to causes 30% of the maximal contractile response by 148-fold for substance P and by 7-fold for acetylcholine. Phosphoramidon potentiated the contractile response to substance P, but not to acetylcholine, by both the epithelium-intact and denuded tissues (P less than 0.05). However, the degree of enhancement by phosphoramidon was much greater in the intact tissues. With phosphoramidon treatment, therefore, the difference in responsiveness to substance P between the intact and denuded tissues was reduced from 148-fold to 18-fold. This effect of phosphoramidon suggests that the hyperresponsiveness to substance P of epithelium-denuded airway tissue is largely because of removal of neutral endopeptidase. Because all tissues were treated with indomethacin, the leftward shifts in substance P and in acetylcholine responsiveness induced by epithelium removal further suggest that an epithelium-derived noncyclooxygenase factor other than neutral endopeptidase also modulates the contractile response to substance P and to acetylcholine.
Fine
J M
JM
Department of Medicine, University of California, San Francisco.
Gordon
T
T
Sheppard
D
D
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D004357:Drug Synergism; D004848:Epithelium / Q000502:physiology; D006020:Glycopeptides / Q000494:pharmacology; D006168:Guinea Pigs; D006652:Histological Techniques; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction; D015260:Neprilysin / Q000037:antagonists & inhibitors; D013373:Substance P / Q000494:pharmacology*; D014132:Trachea / Q000187:drug effects* / Q000502:physiology
D006020:Glycopeptides; D013373:Substance P; D015260:Neprilysin; D000109:Acetylcholine; C008890:phosphoramidon